The xAicell Platform by CD ComputaBio is an advanced AI-driven Virtual Cell Operating System designed to simulate, predict, and optimize cellular behavior before experimental validation. By integrating large-scale single-cell omics data, perturbation datasets, and multi-modal biological information, xAicell enables researchers to transition from empirical trial-and-error experimentation to predictive, computation-first biology.
Our platform constructs high-resolution digital twins of cells, allowing researchers to simulate gene perturbations, drug responses, lineage transitions, and disease dynamics in silico—accelerating discovery while reducing experimental cost and risk.
Biological systems are inherently hierarchical. A mutation at the DNA level cascades through RNA transcription, protein translation, and metabolic signaling, eventually manifesting as a macro-level phenotype or disease state. Traditional computational models are often siloed, focusing only on one layer.
With the advent of single-cell sequencing (scRNA-seq) and spatial transcriptomics, we are drowning in data but starving for actionable knowledge. The human brain cannot synthesize billions of data points to predict how a specific lung cell will react to a combination therapy.
We provide a complete pipeline from data ingestion to predictive simulation.
Our solution includes:
xAicell enables researchers to simulate biological interventions in silico before committing to costly wet-lab validation.
We help clients:
Unlike conventional bioinformatics workflows that deliver descriptive outputs, xAicell emphasizes mechanistic interpretation.
Our solution provides:
The xAicell Intelligent Hub serves as the analytical core of the xAicell Platform. It unifies multi-omics data integration, cellular representation learning, and predictive modeling within a single coordinated framework. Rather than operating as independent tools, the Hub organizes all analytical tasks within a shared high-dimensional cellular landscape. This architecture ensures that clustering, annotation, regulatory inference, and perturbation prediction reinforce one another.
Biological regulation spans multiple layers. The Intelligent Hub integrates:
By jointly modeling these modalities, xAicell builds a unified cellular embedding that captures regulatory relationships across molecular layers while minimizing technical batch effects.
To reveal authentic biological structure, the Hub corrects cross-platform and cross-batch variability.
Key functions include:
This enables reliable identification of cellular subpopulations across large-scale datasets.
The Intelligent Hub performs reference-informed classification with interpretability built in.
Capabilities include:
This approach improves reproducibility and reduces subjectivity in annotation workflows.
Instead of relying solely on correlation-based methods, xAicell infers regulatory architecture from learned cellular embeddings.
The Hub identifies:
These insights provide mechanistic interpretation for downstream predictions.
Cells exist within continuous regulatory landscapes rather than static clusters.
The Hub reconstructs:
Probabilistic modeling allows dynamic reconstruction of state transitions.
Building upon trajectory modeling and regulatory inference, xAicell predicts how cells transition between states under genetic or environmental perturbations.
Outputs include:
This enables forward-looking biological planning rather than retrospective analysis.
Experimental combinatorial perturbations are often infeasible at scale.
The Intelligent Hub enables:
By learning from perturbation datasets, the platform generalizes to unseen scenarios.
Cellular behavior is shaped by spatial context.
The Hub supports:
This allows integration of spatial reasoning into molecular predictions.
To support translational research, xAicell aligns cellular programs across species.
Capabilities include:
This enables transfer of biological insights from model organisms to human systems.
xAicell Platform is reshaping the landscape of gene editing and cellular reprogramming by:
Facilitating virtual modeling of gene-edited cells and animal models, breaking down technical barriers and transforming research from resource-heavy processes to scalable, high-throughput solutions. Automating the screening of functional factors through advanced computational analysis to pinpoint optimal reprogramming pathways, enhancing efficiency by 10 to 100 times.
xAicell Platform is driving innovation in drug discovery by:
Enabling precise identification of target and off-target genes through transcriptomic modeling, addressing critical challenges in small-molecule screening.
Key applications include:
Translating Virtual Cellular Intelligence into Biopharmaceutical Innovation
Beyond academic research, the xAicell Platform is designed to empower industrial drug development pipelines. By leveraging AI-driven cellular modeling and predictive multi-omics analysis, xAicell bridges the gap between computational biology and real-world therapeutic decision-making.
Understanding how biological systems respond to varying drug concentrations is central to pharmacological research.
The xAicell Platform enables advanced dose–response analysis by modeling transcriptional and regulatory changes across different exposure levels.
Our capabilities include:
Drug targets are proteins or biomolecules through which therapeutic agents exert their biological effects. Identifying and validating these targets is one of the most critical steps in drug discovery.
The xAicell Platform performs target analysis through:
Therapeutic resistance remains a major obstacle in oncology and targeted therapy development.
"Resistance-causing markers" refer to genes, proteins, or molecular alterations that enable cells to evade therapeutic intervention.
The xAicell Platform identifies resistance mechanisms by:
| Deliverable | Description |
| Standard Analysis Pack | Reproducible PDF/HTML reports with detailed methodology. |
| Data Assets | Processed results in h5ad/loom/mtx formats; interactive network files. |
| Actionable Lists | Prioritized lists of targets, drivers, biomarkers, and validation combinations. |
This research introduces a "lab-in-the-loop" methodology for constructing virtual cell models capable of predicting functional responses to perturbations like drugs and gene editing. By training AI on high-throughput biological data, the model generates hypotheses that are then experimentally validated. Beyond mere prediction, the study emphasizes "explainability," ensuring the AI can clarify the underlying biological mechanisms behind its results. This framework marks a shift toward a more proactive, discovery-oriented approach in pharmacology and genomic engineering.
Figure 1. Capabilities of the AIVC.1
Interactive Modeling: Agentic Design via CellForge
Introducing an innovative interactive framework called CellForge, this study utilizes AI agents to automate the design and optimization of virtual cell models. These agents are capable of learning from massive biological datasets, autonomously adjusting parameters, and testing model validity within simulated environments. This advancement represents the cutting edge of AI and automated engineering, showing how agentic workflows can significantly accelerate the modeling process and improve the accuracy of complex biological simulations.
Figure 2: (a) Perturbation prediction learns mappings from control cell states to post-perturbation states in highdimensional expression space. (b) Models train on control-perturbed cell pairs across modalities (scRNA-seq, scATAC-seq, CITE-seq) to predict responses to unseen perturbations. (c) CELLFORGE receives datasets and task descriptions, autonomously designing models for predicting expression under novel perturbations (pi ∈ Ptest). (d) System workflow.2
The xAicell Platform represents a paradigm shift in how biological systems are studied, modeled, and engineered. By integrating multi-omics data, regulatory modeling, perturbation simulation, and AI-driven reasoning within the xAicell Intelligent Hub, CD ComputaBio delivers a unified framework for predictive cellular analysis. In an era defined by data abundance and experimental cost, predictive modeling is no longer optional — it is essential. Contact us today to schedule a technical consultation with our computational biology team and learn how our specialized services can accelerate your research.
References:
